Pearson, Jean-Claude Veille, Shahbudin Rahimtoola, et al. Peripartum Cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health)Workshop Recommendations and Review. JAMA 2000;283(9):1183-88.
Incidence and outcome of peripartum cardiomyopathy from a tertiary hospital in South India. Trop Doct. Jul 2009;39(3):168-69.
Peripartum cardiomyopathy. Int J Gynaecol Obstet. Nov 2006;95(2):104-09.
Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 2007;93:488-90.
Microchimerism: Expanding new horizon in human health or incidental remnant of pregnancy? Lancet 2001;358: 2011-12.
Brief communication: Outcomes of subsequent pregnancy after peripartum cardiomyopathy: A case series from Haiti James D. Ann Intern Med. 2006;145:30-34.
Peripartum cardiomyopathy: Analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/Apo-1. J Am Coll Cardiol 2000;35:701-05.
Peripartum cardiomyopathy: Experiencesat King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop Doct 1995;25:118-23.
Pregnancy-associated cardiomyopathy: Clinical characteristics and a comparison between early and late presentation. Circulation 2005;111: 2050-55.
Peripartum cardiomyopathy. Curr Treat Options Cardiovasc Med 2001;3:469-80.
Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N Engl J Med 2001;344:1567-71.
